Skip to content.

Spotlight

Featured

Perspectives
Why we invested in OpenTrade
1 / 7
Read more
Perspectives
Why we invested in Infact
2 / 7
Read more
Perspectives
Why we invested in trumpet
3 / 7
Read more
Perspectives
Why we invested in Instinct
4 / 7
Read more
Perspectives
Why we invested in Treefera
5 / 7
Read more
Perspectives
Why we invested in Oriole Networks
6 / 7
Read more
Perspectives
Why we invested in Gridcog
7 / 7
Read more

Web

Ed Lascelles, Partner, speaks with Forbes on the launch of the new Radia 2024 programme

Not Enough Women Are Pitching To VCs: Will An Accelerator Help?

Read the article >
Web

Universities & pharma companies need each other to create world-changing medicines

Simon Goldman highlights the need of closer partnerships between pharma and universitites on Pharmaforum

Read the article >
Web

Bloomsbury GTx announces publication of article highlighting preclinical data from BGT-NPC programme.

A potential new brain-targeted therapeutic for the treatment of Niemann-Pick Type C Disease (NPC).

Read the article >
Web

Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

Read the article >
Web

Leigh Brody, UCLTF Investor | Career in Discovery Podcast

Leigh Brody, UCLTF investor on TalentSingular’s ‘Careers in discovery’ podcast

Read the article >
Web

Orchard Therapeutics’ new life-saving gene therapy to treat MLD | BBC News

UCLTF’s company has developed a life-saving gene therapy drug now available on the NHS

Read the article >